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INTRODUCTION 
 
According to authoritative physiology textbooks skeletal muscle contributes about to 40% 
of body weight in human. Apparently this proportion shows a large individual variety, but in 
any case, skeletal muscle has a major part in balancing the functions of the whole organism. 
As a major ruler of general health conditions, skeletal muscle has been recognised ages 
ago, and beside this, nowadays it is rediscovered from endocrine and metabolic aspects. 
The considerable complexity of skeletal muscle is characterized by the type of its fibers. 
In mammals, four major fiber types are distinguished according to three main features; (1.) 
the dominantly expressed myosin heavy chain (MyHC), (2.) the twitch speed and (3.) the 
metabolic functions. These properties together characterise the muscle “phenotype”. The main 
contractile element MyHC isoforms are the most frequent markers, but they are not the only 
molecules that determine the muscle phenotype; the contraction speed is controlled by the 
MyHC isoforms, but the rate of relaxation depends on the SERCA isoforms. 
The corresponding slow and fast MyHC and SERCA isoforms are usually expressed 
in coordination in muscle fibers suggesting that they are subject to common regulatory 
mechanism. This regulatory mechanism is mainly controlled by the electric component of 
innervation which is a major determinant of muscle type in normal use. 
Based on a previous study from our laboratory on regenerating muscle, we hypothesized 
that the impact of nerve activity on the expression of SERCAs differs from that on the 
corresponding MyHC isoforms in the normal soleus muscle. In order to test this hypothesis, 
we denervated the hindlimb of the rat (HD). To further refine our study, we compared this 
intervention with selectively denervating the soleus (SD) thereby leaving the other hindlimb 
muscles intact and therefore render the innervated soleus to passive movement. The soleus 
muscle practically contains two fiber types, type I which has slow-twitch and oxidative 
metabolism and type IIA which has fast-twitch and oxidative-glycolitic metabolism. We 
assumed that the adaptation to passive movement might affect the levels of the MyHC and 
SERCA isoforms differently in SD than in HD soleus fibers. 
The role of skeletal muscle is also significant in metabolism and as a major glucose user it 
is a main target of insulin. Insulin deficient diabetes (type I) can be induced in rodents by 
streptozotocin-treatment. Streptozotocin (STZ) is a fungal toxin which damages the insulin 
producing β-cells of the pancreatic island. Lack of insulin observed in type I diabetes restricts 
glucose uptake and severely affects metabolism, function and morphology of muscle. Stz-
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rats develop peripheral neuropathy and a slow-to-fast transition of fiber types in the soleus. 
The conversion from slow to fast muscle phenotype declines the level of slow myosin heavy 
chain (MyHC1) and increases the levels of fast myosins (MyHC2a, MyHC2x and MyHC2b). 
The coordinated expression of the corresponding SERCA isoforms is functionally relevant 
and characteristic to this conversion. However, current research has shown that the level of 
calcineurin, a calcium-calmodulin dependent serine phosphatase is declined in stz-rats faster 
than the level of slow myosin, and the muscle specific overexpression of calcineurin improves 
insulin action, we suggested that regulators of the Ca2+ homeostasis like SERCAs might also 
respond relatively rapidly to blood glucose level in skeletal muscle.
 
AIMS
In this work we wanted to describe the changes of MyHC and SERCA levels in three 
pathological conditions of the rat soleus muscle: selective denervation (SD), hindlimb 
denervation (HD) and streptozotocin induced diabetes (stz-diabetes). We aimed to determine 
the mRNA, protein levels and fiber-expression of MyHC1, MyHC2a, SERCA2a and 
SERCA1 in these conditions. Putting together the results we wished to extend the present 
view about the regulation of MyHC and SERCA isoforms in skeletal muscle. 
 
MATERIALS AND METHODS
 
Selective and hindlimb denervation.  Male Wistar rats 3 months of age and weighing 280-
350g were used for the experiments. Approximately 1 cm of the sciatic nerve high in thigh 
was cut out in the hindlimb-denervation (HD) group. In the selectively-denervated (SD) 
group, 0.3 cm of the soleus nerve was cut out. After denervation, the soleus muscles were 
dissected at 3, 7 or 14 days and frozen in isopentane cooled by boiling liquid nitrogen. 
Normal muscles were gained from untreated animals We also used the soleus of normal and 
HD 200-215g female Wistar rats to compare our results with those of Schulte et al. (1994).
Streptozotocin-induced diabetes. Rats with this treatment were prepared in the 
laboratory of Dr. Ágota Vér, (Institute of Medical Chemistry, Molecular Biology and 
Pathobiochemistry, Semmelweis University). In case of hyperglycaemic model the 
experiments were performed on 4-week-old male Wistar rats (weighing 170 ± 40 g). Rats 
were rendered diabetic with streptozotocin (65 mg/kg i.v) and only with plasma glucose 
concentrations above 15 mmol /l were included in the study. Vehicle-treated rats served 
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as controls. Four weeks after the induction of DM (defined as day 0) the animals were 
anaesthetized and sacrificed by decapitation. The soleus muscles were dissected.
Ratio RT-PCR. RNA extraction and reverse transcription were carried out as described 
previously. The RNA was extracted with the shorter version of acid-guanidinium-phenol-
chlorophorm method. Total RNA level was determined from its UV-absorption at 260nm and 
280nm. The cDNA was transcribed from 1µg total RNA. For determination of SERCA1a/
1b or SERCA1/SERCA2 ratios the same primers were used in one PCR mix. In case of 
SERCA1/SERCA2 the amplified fragments were identified by restriction digest. All PCR 
cycles were adjusted to the logarithmic/linear amplification phase and the products analyzed 
on a 6% (wt/wt) polyacrylamide gel. 
Protein determination. Total protein levels were measured by the BCA method using the 
NanoDrop spectrophotometer. The crude homogenate made in the first step of the SERCA 
extraction was used to determine the total protein level.
Immunoblotting. SERCA and MyHC protein isoforms were measured in extracts of the same 
muscles. The muscles were homogenized in 2.5 ml of 20% sucrose, 5 mM HEPES (pH 7.5) 
and proteinase inhibitor cocktail in the cold room. To extract myosin the first centrifugation 
(1000g x 10 min) pellet was used. For SERCA determination the mitochondrial-microsomal 
(sarcoplasmic) pellet (200 000g x 30 min) was analysed. Amounts of extracts corresponding 
to equal parts of the muscles were loaded on each lane of the gel both for SERCA and myosin 
analysis. The primary antibodies were hybridized with HRP-conjugated 2nd antibodies and 
visualized by Ni-enhanced DAB staining or, in case of MyHC2a, by the ECL-method and 
quantified by densitometry. 
Immunocytochemistry. Serial cryosections of 20 μm thickness from the central part of 
the muscles were cut and processed for immunostaining. Sections were incubated in 5% 
dried milk in PBS for 20 min to block nonspecific binding sites then incubated overnight 
with primary antibodies and then with peroxidase-conjugated secondary for 60 min. The 
immunocomplexes were visualized by DAB staining.
Fiber cross-sectional areas. The cryosections were made in the same way as in 
immunocytochemistry. The sections were stained by hematoxylin-eosin. We calculated the 
fiber cross-sectional areas (CSAs).
Statistics. We used unpaired t-tests to determine the significant differences. We considered 
p<0.05 significant, p<0.01 very significant and p<0.001 highly significant. 2–4 animals 
were used for the mRNA studies, 3–4 animals for the immunoblots, 3 animals for the 
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immunohistochemistry and at least one hundred fibers were inspected for fiber types from 
each muscle.
 
RESULTS
 
Denervation models
Fresh weight, fiber cross-sectional area, total RNA and total protein levels.
In both conditions of denervation, the fresh weight of the muscles decreased from day 7, 
however this decrease was less pronounced in selectively-denervated  (SD) than in hindlimb-
denervated (HD) muscles on day 14. Also the fiber cross-sectional area was smaller compared 
to normal muscle at all stages in both types of denervation. Upon SD, this decrease was larger 
after day 3, whereas upon HD it was more pronounced after day 7 and 14.
The RNA content decreased in HD soleus at day 7 and 14 while in SD muscles it decreased 
only after two weeks. In SD muscles the RNA level increased first at day 3 and 7 compared to 
the level in HD muscle. 
The total protein levels also decreased after 14 days in both types of denervation but more 
dramatically upon HD than SD.
All together, the fresh weight, the fiber cross-sectional area, the total RNA and protein 
contents were more reduced after two weeks in HD than SD. 
The mRNA levels
The slow-twitch MyHC1 mRNA level declined in from day 7 in HD and on day 14 upon SD.
The level of the slow-twitch muscle-specific SERCA2a mRNA was significantly elevated 
above normal (P<0.05) on day 7 of SD. The mRNA level of the fast oxidative MyHC2a 
changed differently in both types of denervation: in SD it increased on days 3 and 7 compared 
to HDon the same days.
The level of the fast SERCA1 mRNA was significantly increased at day 3 in HD and at day 
3 and 7 inSD. SERCA1 exists in two splice variants: a neonatal SERCA1b isoform (lacking 
a 40-bp alternative exon) and an adult SERCA1a form. Interestingly, whereas the level of the 
adult SERCA1a mRNA did not increase in any of the denervated muscles, the mRNA level 
of the neonatal SERCA1b was higher than normal in all stages of both treatments, except the 
14th day of SD muscles. The increase of SERCA1b mRNA levels was higher in SD than in 
HD soleus muscles during the first week. 
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The MyHC2x mRNA levels showed a pronounced increase in both types of denervations, 
most remarkably on day 3 and 7 in SD, when it was significantly higher than in the HD 
muscles.
The levels of GAPDH mRNA did not change during the denervations so it could be used as 
an adequate reference control level for total mRNA.
 
Protein levels
The MyHC1 protein levels declined significantly only at day 14 of HD, but it decreased 
remarkably in all stages of SD. It seems that the loss of MyHC1 protein is slower in HD than 
in SD muscles.
The SERCA2a protein levels were not significantly altered in any of the types of 
denervations. The MyHC2a protein levels did not seem to change significantly compared 
to the normal level in any of the stages of both types of denervation. However it showed a 
significant decrease at day 14 in HD and at day 7 and 14 in SD compared to the previous 
stages of the same denervation. 
The total SERCA1 (SERCA1a + SERCA1b) protein levels dropped significantly only at day 
14 of HD, but it did not change in SD. We also analyzed female rats weighing 200g using our 
method. In this cases the SERCA1 protein level was significantly lower after 14 days in HD 
than in normal muscles.
 
Immunohistochemical results 
MyHC fiber types: The percentage of slow MyHC1-positive type I fibers decreased in all 
stages of both types of denervation. The decrease was more pronounced in SD than in HD at 
day 3. In agreement with this, the decrease of MyHC1 protein level was larger in SD when 
compared to the HD muscles.
In HD muscles the ratio of MyHC2a-expressing type IIA fibers increased on day 7 and 14 
in comparison with the normal soleus muscles. In SD muscles, the percentage of IIA fibers 
didn’t change compared to normal muscles. On day 7, the ratio of type IIA fibers differed 
significantly between the hindlimb and selective denervation.
Hybrid fibers: There were more MyHC-hybrid fibers in both types of denervation than in the 
normal muscles. The numbers of MyHC-hybrid fibers were higher on day 7 in SD than in HD 
muscles.
SERCA fiber types: Parallel sections were also stained for SERCA1 and SERCA2a. The 
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percentage of pure SERCA2a fibers decreased at day 14 in HD, while in SD muscles it was 
already lower at day 3 and 7. The SERCA1-positive fibers increased only in SD at day 7 and 
14. The number of SERCA-hybrid fibers increased in both types of denervation, but this was 
more pronounced in SD muscles.
Coexpression of MyHCs with the corresponding SERCAs: Next we explored to what extent 
the expression of the corresponding slow or fast isoforms of Ca2+ pumps and myosins 
remained correlated during denervation. First we looked at the expressions of the slow 
isoforms. The correlation between SERCA2a-positive fibers and MyHC1-positive fibers was 
tight in the normal muscles. In HD, the correlation loosened and it totally disappeared in SD 
at day 14. The fast isoforms, the SERCA1-positive and MyHC2a-positive fibers retained a 
relatively tight correlation during both types of denervation.
 
Diabetic model
 
Fresh weight, fiber cross-sectional area, total RNA and total protein levels
The weight and protein content of soleus of stz-rats was not significantly different but the 
cross sectional area was only 83% of that of the control muscles.
 
The mRNA levels
The level of GAPDH mRNA was not different in stz-soleus compared to the controls, 
therefore we used it as an RT PCR control. Normalized levels of SERCA1a and SERCA2a 
mRNAs were not significantly lower in the soleus of stz-rats than in the controls, neither were 
the relative levels of SERCA1 and SERCA2 transcripts. Similarly, there were no significant 
differences in the MyHC1/MyHC2a mRNA levels of stz-treated and control rats.
 
The protein levels 
In accordance with the mRNA levels, the MyHC1, MyHC2a and SERCA1 protein levels 
were not different on immunoblots of the soleus of stz-treated and control rats. However, the 
SERCA2a level was about 50% lower in the soleus of stz-treated rats compared to that of the 
controls. This was in agreement with the observation made on transverse sections that the 
SERCA2a level was decreased in type I fibers of the soleus of stz-rats.
 
Immunohistochemical results
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The percentage of type I fibers showed a tendency to decline in stz-rats but it was not 
statistically different from that of the controls. The ratio of type IIA fibers was also not 
significantly different in stz-soleus compared to the control. The number of hybrid fibers 
expressing both MyHC1 and MyHC2a was about the same in the soleus of diabetic and 
controls rats. The percentage of associated type IIA fibers (two or more fibers together) was 
higher in stz-rats than in the controls. This indicated peripheral neuropathy and a higher rate 
of reinnervation in the stz-treated soleus than in the control muscles.
In the diabetic muscles, SERCA1a was stained in type IIA fibers with similar intensity as in 
the control, but SERCA2a expression in type I fibers was practically not different from the 
background level found in the type IIA fibers. 
 
DISCUSSION
Denervation models
 
The denervations highlight the difference in nerve control of expressions of the MyHC and 
SERCA isoform. In SD the soleus was passively moved by the other hindlimb muscles 
therefore the effect of passivity, which is an attribute of HD was eliminated. However, SD 
had another attribute, the passive movement. In spite of the different additional effects we 
could observe changes that were common in both types of denervation. One of these was the 
switch from slow to fast myosin heavy chains, the other was the less apparent switch from 
slow to fast SERCA isoforms. This extended the earlier observation of our group that the 
expression of SERCA isoforms in regenerating muscle are less or not nerve dependent 
compared to the myosin heavy chain isoforms. Similarly, the lack of decline in SERCA2a 
expression was described in spinal cord isolation, in spinal cord trans-section and in 
overloaded soleus muscles. The largest discrepancy in coordinated protein expression was 
found when upon selective denervation the MyHC1 protein level dramatically decreased 
whereas the SERCA2a did not change. This drop in the level of MyHC1 protein indicated that 
a selective degradation of MyHC1 protein accompanied the slow-to-fast transformation in the 
muscle adapting to passive movement. A parallel drop in the level of SERCA2a was not 
observed, again showing that myosin and Ca2+ pumps respond differently to passive 
movement. Upon denervation, the loss of coordination was more pronounced in selective 
denervation for the slow MyHC1 and SERCA2a than for the fast isoforms. The loss of 
coordinated expression resulted in the appearance of hybrid fibers. More SERCA-hybrid 
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fibers than MyHC-hybrid fibers were found in SD than in HD muscles and SERCA-hybrids 
appeared earlier. This also shows that the expressions of MyHC and of SERCA are 
differentially regulated.
In conclusion, the expression of SERCA and myosin isoforms seems to be separately 
controlled each by a unique set of regulatory factors in the soleus muscle. The slow 
innervation is a major controller for the slow type myosin, while the fast myosin (MyHC2a) 
is more expressed when the slow myosin is declining, however not balanced by an equimolar 
replacement of the fast isoform. The switch of SERCA2a to SERCA1a isoform does not 
coincide, but is rather delayed compared to the switch of the slow-to-fast myosin isoforms. 
As a consequence, the slow type SERCA is not expressed in coordination with the slow type 
myosin in many of the fibers.
 
Diabetic model
The soleus muscle of stz-rats was similar by weight and protein content but the fiber size was 
smaller than in the control. This suggests that the fiber size reflects muscle atrophy earlier 
than the fresh weight or protein content. An increased association of type IIA fibers - an 
indication of peripheral neuropathy - also appears to be an early marker of diabetes in stz-
soleus. Parallel with fiber type association a slow-to-fast fiber transition occurs at 2–3 months 
after stz-treatment. In contrast, we did not detect a significant transition of slow-to-fast 
fibers at 4 weeks. Since the range of streptozotocin doses used for inducing type I diabetes 
is relative narrow in rats, the variance in fiber type shift is more likely due to the duration 
of hyperglycemia than to the applied amount of the toxin. According to the unchanged ratio 
of myosin and SERCA1a in fiber types, the stz-soleus showed similar MyHC1, MyHC2a 
and SERCA1a mRNA and protein levels compared to those of the control. However, the 
expression level of SERCA2a was lower in diabetic soleus type I fibers compared to the 
controls and this was supported by the immunoblot but not the RT PCR results. This shows 
that different mechanisms regulate the levels of the SERCA2a pump and the MyHC1 in the 
stz-soleus. The SERCA2a protein level may decrease in several ways; one of these is the 
increased level of glycolysation. Advanced glycation end products accumulate in the skeletal 
muscle and heart of diabetic animals. Although the levels of both SERCA2a and its inhibitor, 
the phospholamban decrease in diabetes, the phospholamban/SERCA2a ratio becomes higher. 
The levels of reactive oxygen and nitrogen species (ROS and RNS) are elevated and decrease 
the levels of specific proteins like SERCA2a. The expression of SERCA2 isoforms is largely 
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regulated at the level of RNA splicing in the normal heart and slow skeletal muscle, however 
no such mechanism was implicated in the diabetic soleus. The calcineurin-NFAT pathway is 
a key factor of muscle remodelling and it has been reported to decline in stz-induced diabetic 
rats parallel with muscle atrophy. Since SERCA2a is the major pump regulating the level 
of Ca2+ in the sarcoplasm, it is an interesting question how the decrease of SERCA2a level 
reported here is related to the decline of the calcineurin-NFAT pathway in diabetic muscle.
Our results suggest that the SERCA2a protein level is an earlier marker than that of MyHC1 
for muscle diabetes. This implicates that the Ca2+ metabolism reacts more readily to diabetic 
stress than the contractile elements do.
 
Comparison of levels of SERCA and MyHC in denervation and diabetic models
The two denervation models are examples of the effects of acute lack of innervation while 
the diabetic model represents the effects of a chronic metabolic malfunction. These different 
pathological statuses explain the differences between the patterns of changes in the two 
models. In these experimental models fibers size adapts earlier than fresh weight and 
this represents an example of the partial overlap between the effects of acute and chronic 
conditions. 
During denervation the decline of MyHC1 level was not followed by the slow-type 
SERCA2a, showing that this protein is not as strongly dependent on innervation as MyHC1.
In contrast with denervation, in the diabetic model the SERCA2a protein was the first to 
decrease and followed only much later by the decrease of MyHC1. These results show that 
the different mechanisms that regulate the levels of SERCA2a and slow myosin act also 
differently in denervated and diabetic soleus, especially because, the dysregulation occurred 
both at the mRNA and protein levels
Although the detailed patterns of changes were different in the two models, the directions of 
changes point to slow-to-fast transformation in both. Overall, these elements are underlining 
the different layers of regulation of corresponding MyHC and SERCA isoforms, showing 
that the MyHC1 is more dependent on innervation while SERCA2a is more dependent on 
metabolic changes.
 
Novel results in the thesis: 
• The regulation of the corresponding MyHC and SERCA isoforms dyscoordinated in 
denervation, among these the MyHC1 is dependent, the SERCA2a is not dependent on 
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innervation.
• The selective denervation is introduced as a new experimental model to study gene 
expression.
• In the stz-induced diabetes the slow-type SERCA2a is more dependent on metabolic 
status than the slow-type MyHC1.
• The decline of fibers size (CSA) reflects muscle atrophy earlier than that of the fresh 
weight.
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